
Consortium invests €32m in Hoppen
A consortium of new and existing backers has injected €32m into France-based Hoppen, a provider of IT services to the medical sector.
Also backing the business were new investors Extens and Geneo Capital Entrepreneur, as well as existing backers Kreizig Invest, Logoden Participations, Unexo, Sofimac Partners and Crédit Agricole d'Ille-et-Vilaine. Sofimac Partners invested via its €20m Breizh Up fund.
Hoppen recently acquired Telecom Services, a provider of IT and multimedia services to healthcare institutions, from private holding vehicle Oxydis.
Seed funding was first provided to Hoppen in 2014 and Generis Capital injected €8m into the business three years later, according to news channel Frenchweb.
Company
Founded in 2011, Hoppen provides IT services designed to optimise the internal flows and processes of healthcare businesses. It claims its products save time for staff and improve the traceability of the medical tasks. Based in Cesson Sévigné, the business now employs 300 people and generates revenue of €25m.
People
Hoppen – Matthieu Malledant, Sebastien Dure (founders).
Advisers
Equity – Chammas & Marcheteau (legal); PDGB Avocats (legal); Altair Avocats (legal); Apollo Avocats (legal).
Company – Ryder & Davis (corporate finance); Chammas & Marcheteau (legal); Avoxa (legal); Make It Work (strategic due diligence); D'Ornano & Associes (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater